Paper41596012
Bioengineered Cellular and Acellular Therapies for Ischemic Heart Disease in Clinically Relevant Models.
Muir KC and 7 others. Bioengineering (Basel), 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Bioengineered Cellular and Acellular Therapies for Ischemic Heart Disease in Clinically Relevant Models. Papers, record 41596012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41596012
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bioengineered Cellular and Acellular Therapies for Ischemic Heart Disease in Clinically Relevant Models.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 1R01HL046716-00 | NIH HHS | United States | R01HL046716 | PubMed | NIH RePORTER |
| 1R01HL128831-00 | NIH HHS | United States | R01HL128831 | PubMed | NIH RePORTER |
| 1T32HL160517-03 | NIH HHS | United States | T32HL160517 | PubMed | NIH RePORTER |
References194
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24805242 | c-kit+ cells minimally contribute cardiomyocytes to the heart. | Nature | 2014 | https://conductscience.org/library/papers/24805242 | PubMed |
| 2 | 29570208 | Sheep can be used as animal model of regional myocardial remodeling and controllable work. | Cardiol J | 2019 | https://conductscience.org/library/papers/29570208 | PubMed |
| 3 | 20395342 | Challenges in the translation of cardiovascular cell therapy. | J Nucl Med | 2010 | https://conductscience.org/library/papers/20395342 | PubMed |
| 4 | 38885303 | Advanced Cardiac Patches for the Treatment of Myocardial Infarction. | Circulation | 2024 | https://conductscience.org/library/papers/38885303 | PubMed |
| 5 | 34409022 | Comparison of Swine and Human Computational Hemodynamics Models for the Study of Coronary Atherosclerosis. | Front Bioeng Biotechnol | 2021 | https://conductscience.org/library/papers/34409022 | PubMed |
| 6 | 34793116 | Extruded Mesenchymal Stem Cell Nanovesicles Are Equally Potent to Natural Extracellular Vesicles in Cardiac Repair. | ACS Appl Mater Interfaces | 2021 | https://conductscience.org/library/papers/34793116 | PubMed |
| 7 | 37554270 | Engineering strategies and optimized delivery of exosomes for theranostic application in nerve tissue. | Theranostics | 2023 | https://conductscience.org/library/papers/37554270 | PubMed |
| 8 | 15812508 | Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. | Nat Med | 2005 | https://conductscience.org/library/papers/15812508 | PubMed |
| 9 | 19081827 | Zebrafish Heart Regeneration as a Model for Cardiac Tissue Repair. | Drug Discov Today Dis Models | 2007 | https://conductscience.org/library/papers/19081827 | PubMed |
| 10 | 37192972 | Therapeutic angiogenesis based on injectable hydrogel for protein delivery in ischemic heart disease. | iScience | 2023 | https://conductscience.org/library/papers/37192972 | PubMed |
| 11 | 30819021 | Native Coronary Collateral Microcirculation Reserve in Rat Hearts. | J Am Heart Assoc | 2019 | https://conductscience.org/library/papers/30819021 | PubMed |
| 12 | 37888397 | Engineered Vesicles and Hydrogel Technologies for Myocardial Regeneration. | Gels | 2023 | https://conductscience.org/library/papers/37888397 | PubMed |
| 13 | 36768399 | Comparative Analysis of Normoxia- and Hypoxia-Modified Extracellular Vesicle Therapy in Function, Perfusion, and Collateralization in Chronically Ischemic Myocardium. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36768399 | PubMed |
| 14 | 24140081 | Small and large animal models in cardiac contraction research: advantages and disadvantages. | Pharmacol Ther | 2014 | https://conductscience.org/library/papers/24140081 | PubMed |
| 15 | 37065655 | 316Engineered extracellular vesicle-mediated delivery of miR-199a-3p increases the viability of 3D-printed cardiac patches. | Int J Bioprint | 2023 | https://conductscience.org/library/papers/37065655 | PubMed |
| 16 | 40159511 | Preclinical extracellular matrix-based treatment strategies for myocardial infarction: a systematic review and meta-analysis. | Commun Med (Lond) | 2025 | https://conductscience.org/library/papers/40159511 | PubMed |
| 17 | 38444042 | Cardiac progenitor cell therapy: mechanisms of action. | Cell Biosci | 2024 | https://conductscience.org/library/papers/38444042 | PubMed |
| 18 | 28249798 | Mesenchymal stem cells-derived extracellular vesicles, via miR-210, improve infarcted cardiac function by promotion of angiogenesis. | Biochim Biophys Acta Mol Basis Dis | 2017 | https://conductscience.org/library/papers/28249798 | PubMed |
| 19 | 31219741 | The Extracellular Matrix in Ischemic and Nonischemic Heart Failure. | Circ Res | 2019 | https://conductscience.org/library/papers/31219741 | PubMed |
| 20 | 39897258 | Assessing the Potential Benefits of Stem Cell Therapy in Cardiac Regeneration for Patients With Ischemic Heart Disease. | Cureus | 2025 | https://conductscience.org/library/papers/39897258 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42395877 | Engineered extracellular vesicles for ischemic heart diseases: modification methods, targeted delivery strategies, and multi-modal therapies - A systematic review. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42395877 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41596012
GET https://conductscience.org/api/papers/v1/41596012/references?page=2